Danshuiquan established its headquarters in Beijing in 2007, and set up an office in Shenzhen on October 20, 2007. 20 1 1 to 20 15, respectively, obtained the licenses of the Hong Kong Securities Regulatory Commission and the US Securities Regulatory Commission, managed QFII accounts in some important countries in North America and Northern Europe, and began to lay out the global market.
Danshuiquan has invested in ten varieties in one-time clearance, among which four are pharmaceutical stocks, namely Taiji market value16.02-10.05% and 377 1 0,000 shares, with a market value of 55 million yuan; Zhejiang Pharmaceutical (6002 16) and Guba (14.870.20%) have 48,255,438+0,000 shares; Renfu Pharmaceutical holds 565,438+0,000,000 yuan (offer 65,438+05,740.64%, 65,438+00,760,000 shares; Fosun Pharma holds 65.438+0.90 billion yuan (quoted price is 44.920.38%, 654.38+0.3 1. 1.00 million shares, holding 448 million yuan.
Extended data
20 1 1 Danshuiquan (Hong Kong) Investment Management Co., Ltd. was established and obtained the No.4 and No.9 licenses issued by the Hong Kong Securities Regulatory Commission. In the same year, Foreign Trade Trust, Danshuiquan Excellence Phase I, Special Account Product Win-Win Phase X, Xiamen Trust Target Return Phase VI and Danshuiquan were established.
In 20 12, Danshuiquan cooperated with ICBC for the first time and established Golden Lion 15 1. In 20 13, the company pioneered the establishment of the first overseas special account product, and successfully won the bid for the gold QFII account management qualification of a North American country. On 20 14, a Nordic country successfully won the bid for the gold QFII account.
Although the business of Danshuiquan is doing well, by the end of 20 14, the assets managed by Danshuiquan, which was established seven years ago, were still less than 5 billion yuan. However, in the second year of the 20 15 bull market, Zhao Jun and Danshuiquan were established. Danshuiquan seized the opportunity and issued 134 private equity funds within one year, which greatly exceeded other private equity giants.
Analysts worry that lululemon¡¯s valuation is too high; LVMH¡¯s global store count is approaching 5,500